"Telix confirms that payments noted under section 6.1 of the accompanying Appendix 4C
include payments to ABX-CRO advanced pharmaceutical services Forschungsgesellschaft 3
for the provision of clinical and analytical services for its programs, and to Directors for director
fees."
I believe this is the part of the announcement you are referring to?
ABX-CRO is involved in advanced pharmaceutical services and is a different company. The CRO division specializes in therapeutic radiopharmaceuticals.
Sorry to disappoint.
SpendaCollect - 'immense revenue potential', page-15
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $43.24M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.9¢ | $2.109K | 231.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 10001408 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 4124830 | 11 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| SPX (ASX) Chart |